Myeloma Patients Europe
MPE launches the Myeloma and AL Amyloidosis European Clinical Trial Navigator
23 April 2024 — Brussels, Belgium — Myeloma Patients Europe (MPE) has launched today the English version of the Myeloma and AL Amyloidosis European Clinical Trial Navigator, an online search tool to learn about and find clinical trials for myeloma, monoclonal gammopathy of undetermined significance (MGUS), smouldering multiple myeloma (SMM) and AL amyloidosis in Europe….
Myeloma Patients Europe report finds huge inequalities in access to myeloma clinical trials in Central and Eastern Europe
Brussels, 30 November 2022 – Myeloma Patients Europe (MPE) has launched a first-of-its-kind advocacy report on Addressing access barriers to myeloma clinical trials in Central and Eastern Europe (CEE)
